Taken together, these findings indicate that MC4R signaling strongly modulates D1R signaling, making it an interesting target for pharmacotherapies to combat psychopathologies such as addiction and obesity. The gene discussed is DRD1; the disease is obesity due to melanocortin 4 receptor deficiency.